Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2004 February;95(1)

ULTIMO FASCICOLOMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


Periodicità: Bimestrale

ISSN 0026-4806

Online ISSN 1827-1669


eTOC

 

Minerva Medica 2004 February;95(1)

 REVIEW 

Minerva Medica 2004 February;95(1):1

Epatite autoimmune. Conoscenze attuali

Durazzo M., Premoli A., Morello E.


 REVIEW 

Minerva Medica 2004 February;95(1):11-24

Ribozymes as antiviral agents

Bartolomé J., Castillo I., Carreño V.


 REVIEW 

Minerva Medica 2004 February;95(1):25-34

Cancro prostatico e screening con test PSA

Camici M.


 REVIEW 

Minerva Medica 2004 February;95(1):35-52

Fibromialgia: stato dell'arte

Fietta P.


 ARTICOLI ORIGINALI 

Minerva Medica 2004 February;95(1):53-64

Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis

Capello D., Berra E., Cerri M., Gaidano G.


 ARTICOLI ORIGINALI 

Minerva Medica 2004 February;95(1):65-70

Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis

Actis G. C., Lagget M., Rizzetto M., Fadda M., Palmo A., Pinna-Pintor M., Morino F.


 ARTICOLI SPECIALI 

Minerva Medica 2004 February;95(1):71-8

The evaluation of the results of clinical trials: surrogate end points and composite end points

Gensini G. F., Conti A. A.


inizio pagina